Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13554886 | 1.00 | BLM (0.56) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL8984582 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL5074983 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL8984494 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL1875589 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL8984664 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL8984408 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL8230933 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL3685397 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 | |
| SCHEMBL16536902 | 0.98 | ACE2 (0.55) | BLMLTA4HGABRR1CYP1A2ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2134315-B1 | TATTOO-REMOVING COMPOSITION | SK AGELESS CONCEPT GMBH (DE) | 2016-11-09 | — | — | EP | claimed |
| US-20100119466-A1 | TATTOO-REMOVING COMPOSITION | SK AGELESS CONCEPT GMBH (DE) | 2010-05-13 | — | — | US | claimed |
| EP-2134315-A1 | TATTOO-REMOVING COMPOSITION | SK ageless-concept GmbH (DE) | 2009-12-23 | — | — | EP | claimed |
| WO-2008128514-A1 | TATTOO-REMOVING COMPOSITION | FAGRON GROUP B.V. (NL) | 2008-10-30 | — | — | WO | claimed |
| EP-1000076-A1 | HEXADECASACCHARIDE-PROTEIN CONJUGATE VACCINE FOR $i(SHIGELLA DYSENTERIAE) TYPE 1 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-17 | — | — | EP | claimed |
| WO-1999003871-A1 | HEXADECASACCHARIDE-PROTEIN CONJUGATE VACCINE FOR SHIGELLA DYSENTERIAE TYPE 1 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-01-28 | — | — | WO | claimed |
| US-11795241-B2 | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same | CYDEX PHARMACEUTICALS, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| CN-114044886-B | Production method of polycaprolactone | 青岛科技大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-113993914-B | Amide compound, polymerizable composition, cured product, and method for producing same | 株式会社ADEKA | 2023-05-09 | — | — | CN | disclosed |
| US-20210147582-A1 | FRACTIONATED ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2021-05-20 | — | — | US | disclosed |
| US-10851184-B2 | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same | CYDEX PHARMACEUTICALS, INC. (US) | 2020-12-01 | — | — | US | disclosed |
| US-10800861-B2 | Alkylated cyclodextrin compositions and processes for preparing and using the same | CYDEX PHARMACEUTICALS, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| US-10633462-B2 | Manufacturing process for cyclodextrin derivatives | CYDEX PHARMACEUTICALS, INC. (US) | 2020-04-28 | — | — | US | disclosed |
| EP-0680522-A1 | METALLIZED POLY(LACTIC ACID) FILMS. | DU PONT (US) | 1995-11-08 | — | — | EP | disclosed |
| WO-1995007919-A1 | METHOD FOR DOSING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. (US) | 1995-03-23 | — | — | WO | disclosed |
| US-5391723-A | Oligonucleotide conjugates | NEORX CORPORATION (US) | 1995-02-21 | — | — | US | disclosed |
| US-5382617-A | Heat resistant polymers with boron oxide | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
| WO-1994017220-A1 | METALLIZED POLY(LACTIC ACID) FILMS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-08-04 | — | — | WO | disclosed |
| CN-1016778-B | spiro-substituted glutaric acid monoamides | PFIZER LTD (GB) | 1992-05-27 | — | — | CN | disclosed |
| US-4140712-A | 20-Hydroxy-prostaglandins | ONO PHARMACEUTICAL COMPANY (JP) | 1979-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10633462-B2 | Manufacturing process for cyclodextrin derivatives | DCXR, AGL, OSTC | BLM 3365/4885LTA4H 1526/4885GABRR1 3386/4885 |
| US-11795241-B2 | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same | AGPS, DDOST, ALG1 | BLM 2076/4885LTA4H 1173/4885GABRR1 2899/4885 |
| US-20210147582-A1 | FRACTIONATED ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME | AGPS, DDOST, ALG1 | BLM 2076/4885LTA4H 1173/4885GABRR1 2899/4885 |
| US-10800861-B2 | Alkylated cyclodextrin compositions and processes for preparing and using the same | AGL, AGPS, MGAM | BLM 3226/4885LTA4H 729/4885GABRR1 2114/4885 |
| US-10851184-B2 | Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same | AGPS, DDOST, ALG1 | BLM 2076/4885LTA4H 1173/4885GABRR1 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.